If your skin gets red, inflamed and is prone to flushing, you may have a condition called Rosacea. Rosacea is a skin condition characterized by a reddening of the cheeks, nose, chin and/or forehead. It may also include the appearance of papules and pustules which are acne-like pimples. While it is very common, affecting more than 14 million Americans*, many of those with rosacea don’t even realize they have it.
Obagi Medical Products, a leading skin care company, now brings you an effective way to manage your rosacea. The Rosaclear System provides gentle, dermatologist-tested and allergy-tested skincare to calm your inflamed, irritated skin. It’s a specially formulated, prescription-based regimen that is non-comedogenic, so it won’t clog your pores.
- The Gentle Cleanser calms and smoothes your skin while helping to remove bacteria and other irritating residues.
- The Metronidazole Topical Gel USP, 0.75% (prescription only) is indicated for topical application in the treatment of inflammatory papules and pustules of rosacea.
- The Hydrating Complexion Corrector protects and moisturizes your skin, while helping to reduce the appearance of redness by utilizing multiple calming agents, anti-inflammatory agents and light-reflecting minerals.
- The Skin Balancing Sun Protection SPF 30 is a specially formulated, chemical-free, tinted UVA/UVB sunscreen, which easily blends with your skin to help reduce the appearance of redness and blotchiness.
The Rosaclear System contains calming and anti-inflammatory agents, such as licorice, aloe, lavender and sea whip. These ingredients soothe your skin and effectively reduce and minimize the visible redness and blotchiness associated with rosacea, while light-reflecting minerals balance your complexion immediately.
If you are interested in trying the Rosaclear system by Obagi, simply call or stop by the clinic. Our skin care specialists will be happy to discuss this system to you.
*American Academy of Dermatology and the National Rosacea Society
Posted: March 1st, 2010 under Uncategorized.
Comments: none